Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults

Cytomegalovirus can cause debilitating and life-threatening disease in newborns infected in utero and immunocompromised individuals, including transplant recipients. RG7667 is a unique combination of two monoclonal antibodies that binds glycoprotein complexes on the surface of cytomegalovirus and in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Ishida, Julie H., Burgess, Tracy, Derby, Michael A., Brown, Pearline A., Maia, Mauricio, Deng, Rong, Emu, Brinda, Feierbach, Becket, Fouts, Ashley E., Liao, X. Charlene, Tavel, Jorge A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2015
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4505204/
https://ncbi.nlm.nih.gov/pubmed/26055360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00523-15
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados